Published Date: 26-Sep-2021
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Cardiovascular Ultrasound Market, published by KBV research, The Global Cardiovascular Ultrasound Market size is expected to reach $2.6 billion by 2027, rising at a market growth of 10.4% CAGR during the forecast period.
The Doppler segment procured the highest revenue share of the global market in 2020. Doppler system has witnessed massive demand as they offer sharp images in a shorter time. The technique is attaining popularity in emerging nations, like India and China due to the surge in penetration of technologically sophisticated systems in such economies.
The hospitals segment garnered the prominent revenue share of the cardiovascular ultrasound market in 2020. Medical imaging has been a significant driver for outpatient profit; hence several mid-to-large-sized hospitals deploy medical imaging devices inside their premises.
North America garnered the maximum revenue share of the cardiovascular ultrasound market in 2020. This is because of the advanced infrastructure in healthcare units and the huge acceptance of CVUS in preventive medicine. In the U.S., the payments for Medicare are based on several aspects such as conversion factors, relative value units, and geographic practice cost indices. Medicare comes along with the latest norms, which helps in the development of reimbursement policy. The growth of the regional market would be propelled by the favorable reimbursement policy and regulatory outlook.
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Siemens AG (Siemens Healthineers), Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Mindray Medical International Limited, Chison Medical Technologies Co., Ltd., FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation) and Esaote SpA.
By End Use
Unique Offerings from KBV Research